TG Therapeutics Inc (NASDAQ: TGTX) is -6.98% lower on its value in year-to-date trading and has touched a low of $12.84 and a high of $36.84 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TGTX stock was last observed hovering at around $30.05 in the last trading session, with the day’s loss setting it -2.05%.
Currently trading at $28.00, the stock is -11.96% and -8.87% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.06 million and changing -6.82% at the moment leaves the stock 26.65% off its SMA200. TGTX registered 55.38% gain for a year compared to 6-month gain of 43.22%. The firm has a 50-day simple moving average (SMA 50) of $30.6273 and a 200-day simple moving average (SMA200) of $22.044325.
The stock witnessed a -17.36% loss in the last 1 month and extending the period to 3 months gives it a 25.96%, and is -13.93% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.91% over the week and 5.50% over the month.
TG Therapeutics Inc (TGTX) has around 264 employees, a market worth around $4.22B and $264.79M in sales. Fwd P/E is 28.83. Profit margin for the company is -5.42%. Distance from 52-week low is 118.07% and -24.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.23%).
The EPS is expected to shrink by -58.33% this year.
TG Therapeutics Inc (TGTX) Top Institutional Holders
393.0 institutions hold shares in TG Therapeutics Inc (TGTX), with institutional investors hold 73.35% of the company’s shares. The shares outstanding are 155.78M, and float is at 140.50M with Short Float at 19.32%. Institutions hold 66.38% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.69 million shares valued at $243.58 million. The investor’s holdings represent 9.3645% of the TGTX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.39 million shares valued at $$202.6 million to account for 7.7891 of the shares outstanding. The other top investors are STATE STREET CORP which holds 6.7 million shares representing 4.5798% and valued at over $119.12 million, while SOLEUS CAPITAL MANAGEMENT, L.P. holds 2.4934 of the shares totaling 3.65 million with a market value of $64.85 million.
TG Therapeutics Inc (TGTX) Insider Activity
#####
Still, SEC filings show that on Nov 11 ’24, Lonial Sagar (Director) disposed off 5,000 shares at an average price of $30.44 for $0.15 million. The insider now directly holds 100,195 shares of TG Therapeutics Inc (TGTX).
